Hypertrophic cardiomyopathy (HCM) is the most common inherited cardiomyopathy. It is characterized by intricate phenotypic and genetic manifestations. This review summarizes the Current treatment modalities and  the Emerging Therapies

M Siddharth completed his DM Cardiology from Rajiv Gandhi University of Health Sciences in 2019 in India. He has worked in various Capacities in both corporate Hospitals and Government Hospitals all over India. Since 2022 he has been working as Consultant with Southern Railway HQ, Chennai, India. He has presented papers in numerous Conferences. His special areas of Interest Interventional Cardiology, Structural heart interventions and Heart Failure are with area of interest.